News

  • Early diagnosis can improve ‘dementia journey’, charity says

    Recognising dementia symptoms and receiving an early diagnosis can help people with the condition to "live better for longer", a support charity has said. The Alzheimer’s Society worked with other agencies to reduce stigma and run "myth-busting" events across the Isle of Man for Dementia Awareness Week. Claire Cubberley from the society said while it [...]

  • Simple test can predict risk of severe liver disease

    A new blood test can predict the risk of severe liver disease up to 10 years in advance, raising hopes for earlier detection of cirrhosis and liver cancer. The model, called CORE, combines five factors: age, sex and levels of three common liver enzymes (AST, ALT and GGT), which are routinely measured during health checks. [...]

  • Key change to urine could be early warning sign of dementia, researchers say

    Foamy urine may be an early warning sign for dementia, raising risk by up to almost 40 per cent, researchers have found. The symptom, which can make people go to the toilet more often, may indicate high levels of albumin – a protein that leaks into urine when kidney filters are damaged. Swedish researchers tracked [...]

  • Adults can bounce back to good health, study finds

    Nearly one in four older adults with poor health and well-being can return to good condition within three years, challenging assumptions that decline in later life is inevitable. The research defined recovery to “optimal well-being” as the absence of serious conditions affecting daily life, alongside good physical health, psychological stability, happiness and life satisfaction. Researchers [...]

  • Tool could detect early signs of Alzheimer’s

    Researchers in the US are testing technology that could help doctors detect Alzheimer’s disease early and slow its advance. The project focuses on the brain’s metabolism — how it uses glucose, the sugar that fuels thought, movement and emotions. The research is led by Travis Gibbons, assistant professor in the Department of Biological Sciences, at [...]

  • Study finds link between circadian rhythms and bone resorption

    How our bodies break down and remove old and damaged bone tissue is linked to our inner circadian clock, according to a new study. Researchers focused on the processes involved in bone renewal: bone resorption (which allows the body to breakdown and remove old or damaged bone) and bone formation (which builds new bone). The [...]

  • Drinking even small amounts of alcohol may increase dementia risk, study finds

    Any amount of alcohol consumption may increase dementia risk, according to a new large-scale study. The findings challenge the belief that light or moderate drinking might protect brain health, with genetic evidence suggesting harm at all levels. A threefold increase in weekly drinks raised dementia risk by 15 per cent. Scientists combined observational data from [...]

  • NHS warns against dismissing symptoms as ‘natural part of ageing’

    The NHS has warned people not to ignore four key dementia symptoms, stressing they are not just a natural part of getting older. In guidance shared on social media platform X, the health service said that memory loss, difficulty concentrating, struggling with familiar tasks and mood changes could indicate cognitive decline rather than normal ageing. [...]

  • Round up: Joint venture to advance Klotho-based therapies, and more

    Agetech world explores the latest business and investment developments in the world of ageing and longevity. Joint venture to advance Klotho-based therapies Nevada-based Avant Technologies and Singapore-based biotech company Austrianova are entering into a joint venture and license agreement to establish Klothonova - a new company focused on pioneering cell-based therapies utilising encapsulated Klotho-producing cells. [...]

  • Bone breakthrough could reverse osteoporosis

    Scientists have uncovered a mechanism that could lead to treatments aimed at reversing osteoporosis rather than only slowing its progression. The finding involves a cell receptor called GPR133, also known as ADGRD1, which regulates osteoblasts – the cells that build new bone tissue. When triggered by a compound called AP503, this receptor increased bone strength [...]